Corporate information

Registration country

Company type

Dedicated to the development of novel antibody domains engineered to be stable in the GI tract.

Funding rounds

Profile Country
Unilever Ventures Ltd


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials